Skip to main content

and
  1. No Access

    Article

    Absence of spontaneous response improvement beyond day +100 after autologous stem cell transplantation in multiple myeloma

    The response evaluation after autologous stem-cell transplantation (ASCT) is usually performed at day +100 in patients with multiple myeloma (MM). A recent report suggests that improvement in the response can ...

    C Fernández de Larrea, J Dávila, I Isola, E M Ocio in Bone Marrow Transplantation (2017)

  2. Article

    Open Access

    Patients with relapsed/refractory chronic lymphocytic leukaemia may benefit from inclusion in clinical trials irrespective of the therapy received: a case-control retrospective analsysis

    D Esteban, N Tovar, R Jiménez, R Santacruz, T Baumann, MaC Pastor in Blood Cancer Journal (2015)

  3. No Access

    Article

    Pattern of relapse and progression after autologous SCT as upfront treatment for multiple myeloma

    The achievement of CR is the crucial step for a prolonged PFS and OS after an autologous SCT in multiple myeloma (MM). Unfortunately, even with the use of new regimens and the current high CR rates, most, if n...

    C Fernández de Larrea, R Jiménez, L Rosiñol, E Giné, N Tovar in Bone Marrow Transplantation (2014)